Clinical Trial Update: Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 study of an enteric microgranule formulation of Adrulipase in cystic fibrosis patients with exocrine pancreatic insufficiency has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Adrulipase (Adrulipase)

Snippet

Sponsor: Entero Therapeutics | Conditions: Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19